A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab (MK-3475, NSC #776864) in Addition to Paclitaxel and Carboplatin for Measurable Stage III or IVA, Stage IVB or Recurrent Endometrial Cancer (NRG-GY018)
- Zaid, Tarrik (PI)
- Alaniz, Anne (Key Personnel)
- Darcourt, Jorge (Key Personnel)
- Singh, Monisha (Key Personnel)
- Suri, Anuj (Key Personnel)
Project: Clinical Trial